Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10220790 | Journal of Cataract & Refractive Surgery | 2018 | 6 Pages |
Abstract
In this ex vivo study, ROCK inhibitor reduced endothelial loss and thus, could be used to limit or slow down CEC loss. Rho-associated kinase inhibitor might be used before cataract surgery, especially in high risk patients. This might be a promising new method for preventing pseudophakic bullous keratopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Asaf MD, Anna PhD, Lily MD, Haggay MD, MHA, Irina S. MD, MHA, Mordechai MD, Boris MD, Elisha MD, Zvia MD, Vicktoria MD,